Cours Isodiol International Inc. Canadian Securities Exchange
Actions
ISOL
CA46500L2003
Produits pharmaceutiques
CA 2018 | 19,14 M 26,1 M 17,24 M | CA 2019 | 22,25 M 30,34 M 20,05 M | Capitalisation | 49,96 M 68,13 M 45,02 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,1 M -32,44 M | Résultat net 2019 | -126 M -172 M -114 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,21 M 14,01 M | Dette nette 2019 | 5,22 M 7,12 M 4,71 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+23,84% | 5,56 Md | |
-33,64% | 3,55 Md | |
-5,20% | 3,01 Md | |
-25,56% | 2,64 Md | |
-10,76% | 2,3 Md | |
+42,02% | 1,95 Md | |
+43,15% | 1,52 Md | |
-12,72% | 1,45 Md | |
+41,90% | 1,38 Md |